Coagulation and metastasis: what does the experimental literature tell us? (Q38108356)

29 August 2017

title

Coagulation and metastasis: what does the experimental literature tell us? (English)

1 reference

29 August 2017

main subject

experimental literature

1 reference

Ana M Gil-Bernabé

1

1 reference

29 August 2017

Serena Lucotti

series ordinal

2

1 reference

29 August 2017

Ruth J Muschel

series ordinal

3

1 reference

29 August 2017

language of work or name

English

0 references

publication date

21 May 2013

1 reference

British Journal of Haematology

29 August 2017

published in

1 reference

29 August 2017

volume

162

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

433-441

1 reference

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

29 August 2017

cites work

1 reference

Thrombin inhibitor, argatroban, prevents tumor cell migration and bone metastasis

21 January 2018

1 reference

The relationship between tissue factor and cancer progression: insights from bench and bedside

21 January 2018

1 reference

Antitumor and antimetastatic effect of warfarin and heparins.

21 January 2018

1 reference

Anticoagulant drugs increase natural killer cell activity in lung cancer

21 January 2018

1 reference

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

21 January 2018

1 reference

Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis

21 January 2018

1 reference

Aspirin and cancer risk: a quantitative review to 2011.

21 January 2018

1 reference

Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders

21 January 2018

1 reference

Immunohistochemical identification of tissue factor in solid tumors

21 January 2018

1 reference

Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis

21 January 2018

1 reference

Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview

21 January 2018

1 reference

Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy

21 January 2018

1 reference

Thrombosis and cancer: 40 years of research

21 January 2018

1 reference

The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis

21 January 2018

1 reference

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells

21 January 2018

1 reference

Procoagulant mechanisms in tumour cells.

21 January 2018

1 reference

Microparticles in tumor progression.

21 January 2018

1 reference

Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin

21 January 2018

1 reference

VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice

21 January 2018

1 reference

Mechanisms of thrombus formation

21 January 2018

1 reference

Antimetastatic effects associated with platelet reduction

21 January 2018

1 reference

Contribution of platelets to tumour metastasis.

21 January 2018

1 reference

Initial tumor cell arrest in animals of defined coagulative status

21 January 2018

1 reference

Role of thrombin as a tumor growth factor

21 January 2018

1 reference

Platelet granule secretion continuously prevents intratumor hemorrhage

21 January 2018

1 reference

How platelets safeguard vascular integrity

21 January 2018

1 reference

Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis

21 January 2018

1 reference

Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation

21 January 2018

1 reference

Role of tissue factor in cancer

21 January 2018

1 reference

Tissue factor and its measurement in whole blood, plasma, and microparticles

21 January 2018

1 reference

P-selectin deficiency attenuates tumor growth and metastasis

21 January 2018

1 reference

Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.

21 January 2018

1 reference

Effect of anti-fibrinolytic therapy on experimental melanoma metastasis

21 January 2018

1 reference

Effects of fluid dynamic forces on vascular cell adhesion

21 January 2018

1 reference

Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity

21 January 2018

1 reference

Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin.

21 January 2018

1 reference

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis

21 January 2018

1 reference

Selectins as mediators of lung metastasis.

21 January 2018

1 reference

Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism

21 January 2018

1 reference

21 January 2018

Tissue factor and cancer

1 reference

Elevated tissue factor procoagulant activity in CD133-positive cancer cells

21 January 2018

1 reference

Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis

21 January 2018

1 reference

Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis

21 January 2018

1 reference

CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models.

21 January 2018

1 reference

The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models

21 January 2018

1 reference

Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis.

21 January 2018

1 reference

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

21 January 2018

1 reference

Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms

21 January 2018

1 reference

Overview of metastasis assays

21 January 2018

1 reference

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth

21 January 2018

1 reference

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

Mechanisms of cancer-induced thrombosis in cancer

21 January 2018

1 reference

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

21 January 2018

1 reference

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

21 January 2018

1 reference

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

21 January 2018

1 reference

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

21 January 2018

1 reference

Tissue factor and cell signalling in cancer progression and thrombosis

21 January 2018

1 reference

Tissue factor and protease-activated receptor signaling in cancer

21 January 2018

1 reference

Tissue factor proangiogenic signaling in cancer progression

21 January 2018

1 reference

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study

21 January 2018

1 reference

Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients

21 January 2018

1 reference

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

21 January 2018

1 reference

Emerging insights in tissue factor-dependent signaling events.

21 January 2018

1 reference

Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype

21 January 2018

1 reference

Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis

21 January 2018

1 reference

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis

21 January 2018

1 reference

Warfarin versus low-molecular-weight heparin therapy in cancer patients

21 January 2018

1 reference

PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis

21 January 2018

1 reference

Predictive value of tissue factor bearing microparticles in cancer associated thrombosis.

21 January 2018

1 reference

Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12381

1 reference

29 August 2017

1 reference